JADE2 Human Pre-designed siRNA Set A contains three designed siRNAs for JADE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JADE3 Human Pre-designed siRNA Set A contains three designed siRNAs for JADE3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAG1 Human Pre-designed siRNA Set A contains three designed siRNAs for JAG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAG2 Human Pre-designed siRNA Set A contains three designed siRNAs for JAG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAGN1 Human Pre-designed siRNA Set A contains three designed siRNAs for JAGN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAK-IN-36 (Compound 12e) is a potent and selective inhibitor of Janus Kinase 1 (JAK1) with a IC50 value of 2.2 nM. JAK-IN-36 can be used in the study of autoimmune diseases[1].

JAK1 Human Pre-designed siRNA Set A contains three designed siRNAs for JAK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jak1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Jak1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jak1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Jak1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAK1/2-IN-1 is a potent JAK1 and JAK2 inhibitor with IC50 values of 0.4 nM and 8.1 nM, respectively. JAK1/2-IN-1 also inhibits IL-4 and IL-13 with IC50s of 136.5 nM and 19.1 nM, respectively (WO2023244775A1; Example 33a)[1].

JAK2 Human Pre-designed siRNA Set A contains three designed siRNAs for JAK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jak2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Jak2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jak2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Jak2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAK3 covalent inhibitor-2 (compound J1b) is a selective, orally potent JAK3 inhibitor (IC50=7.2 nM) with low toxicity, anti-inflammatory activity and good bioavailability[1].

JAK3 Human Pre-designed siRNA Set A contains three designed siRNAs for JAK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jak3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Jak3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jak3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Jak3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAKMIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for JAKMIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAKMIP2 Human Pre-designed siRNA Set A contains three designed siRNAs for JAKMIP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAKMIP3 Human Pre-designed siRNA Set A contains three designed siRNAs for JAKMIP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jalapinolic acid (11-Hydroxyhexadecanoic acid; 11-Hydroxypalmitic acid) is a hydroxyhexadecanoic acid[1].

JAM2 Human Pre-designed siRNA Set A contains three designed siRNAs for JAM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAM3 Human Pre-designed siRNA Set A contains three designed siRNAs for JAM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JAML Human Pre-designed siRNA Set A contains three designed siRNAs for JAML gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Janus green is a basic dye.

Janus red is a basic dye.

JARID2 Human Pre-designed siRNA Set A contains three designed siRNAs for JARID2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Jasmine lactone-d2 is deuterated labeled (±)-Cotinine-N-β-Glucuronide (HY-W588194).

JAZF1 Human Pre-designed siRNA Set A contains three designed siRNAs for JAZF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JBC117 is a novel anticancer lead compound targeting Pygo2 PHD. JBC117 can effectively antagonize the cell effect of β-catenin-dependent activity and inhibit the migration and invasion of cancer cells. JBC117 can induce apoptosis[1].

JBP485 (cyclo-trans-4-L-hydroxyprolyl-L-serine) is a dipeptide with anti-hepatotoxic and wound healing properties. JBP485 can be used for research of various kinds of corneal epithelial diseases[1].

JCAD Human Pre-designed siRNA Set A contains three designed siRNAs for JCAD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JCHAIN Human Pre-designed siRNA Set A contains three designed siRNAs for JCHAIN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JD-02 is a novel Hsp90 inhibitor. JD-02 can induce autophagy and apoptosis. JD-02 increses the level of reactive oxygen species[1].

JDP2 Human Pre-designed siRNA Set A contains three designed siRNAs for JDP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JGB-1-155 is a positive allosteric modulators (N-PAMs), which enhances the activity of nicotinamide phosphoribosyltransferase NAMPT with EC50 of 3.29 μM. JGB-1-155 counteracts the oxidative stress, through upregulating the NAD+ in THP-1 human monocytes. JGB-1-155 attenuates TNFα-induced ROS in HT-22 cells [1].

JHY Human Pre-designed siRNA Set A contains three designed siRNAs for JHY gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JJC8-088 is a potent inhibitor of DAT. JJC8-088 is a novel Modafinil-derived ligands. JJC8-088 can be used to study psychostimulant use disorders[1].

JKAMP Human Pre-designed siRNA Set A contains three designed siRNAs for JKAMP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JLB2-110c activates MCRs receptor (mMC4R EC50 = 0.34 nM) and has a strong in vivo appetite suppressant effect[1].

JMJD1C Human Pre-designed siRNA Set A contains three designed siRNAs for JMJD1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis[1].

JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis[1].

JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis[1].

JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis[1].

JMJD1C-IN-1 (compound 193D7) is an inhibitor of JMJD1C with oral activity. JMJD1C-IN-1 targets tumor Treg cells without affecting systemic immune homeostasis[1].

JMJD4 Human Pre-designed siRNA Set A contains three designed siRNAs for JMJD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.